204
Participants
Start Date
December 31, 2015
Primary Completion Date
April 3, 2020
Study Completion Date
April 10, 2020
Smoflipid 20% (investigational lipid for parenteral nutrition)
"Dose: The targeted maximal dose is 3.0 g/kg/day. In patients already receiving parenteral nutrition (PN) before starting study treatment, the dose will either stay at 3.0 g/kg/day or be increased by 1.0 g/kg/day steps to a maximum of 3.0 g/kg/day.~Smoflipid 20% will be infused over 20 - 24 hours, as per hospital policy, at a weight based infusion rate.~Smoflipid 20% will be infused into a central or a peripheral vein."
Intralipid® 20%
"Dose: The targeted maximal dose is 3.0 g/kg/day. In patients already receiving parenteral nutrition (PN) before starting study treatment, the dose will either stay at 3.0 g/kg/day or be increased by 1.0 g/kg/day steps to a maximum of 3.0 g/kg/day.~Intralipid® 20% will be infused over 20 - 24 hours, as per hospital policy, at a weight based infusion rate.~Intralipid® 20% will be infused into a central or peripheral vein."
Mount Sinai Hospital, New York
Steven & Alexandra Cohen Children's Medical Center of NY, New York
Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Children's Hospital of Philadelphia, Philadelphia
Vanderbilt Children's Hospital, Nashville
The Children's Hospital at OU Medical Center, Oklahoma City
Texas Children's Hospital, Houston
UC San Diego Medical Center, San Diego
Rady Children's Hospital San Diego, San Diego
Lucile Packard Children's Hospital, Palo Alto
Yale - New Haven Children's Hospital, New Haven
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
University of Nebraska Medical Center, Omaha
Lead Sponsor
Fresenius Kabi
INDUSTRY